MYGN Dividend History & Analysis | N/A Yield

MYGN has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

Yield 12m -
Payout Ratio -
Growth Rate CAGR 5y -
Consistency Lifetime 1.0%
Yield on Cost 5y -
Payout FCF -
Streak Years -
Dividend Rating 1.00%

Dividends Cash Amount per Share Yearly

This chart shows the yearly cash amount paid as dividends per share. The exact values for each year can be found in the structured dataset with the html-id #yearly_dividend_dataset below.
Dividend Growth Year over Year This chart shows the annual dividend growth rate compared to the previous year.
5 Years Chart with Price and Dividend Yield This chart shows the dividend yield and price over time. Price is displayed as gray area (left axis), yield as dark blue line (right axis), and average yield as orange dashed line.

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap USD Dividend Yield TTM Yield on Cost 5y
ABBV 387,093 M 3.34% 7.54%
AMGN 198,244 M 3.21% 5.93%
GILD 176,133 M 2.79% 5.63%
HLN 46,623 M 1.76% 2.46%
BIM 13,627 M 0.74% 0.75%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap USD Growth Rate Consistency
BTX 1,425 M 134% 95.6%
HLN 46,623 M 30.1% 100%
AMGN 198,244 M 7.84% 100%
BIM 13,627 M 9.76% 96.0%
ABBV 387,093 M 5.98% 100%

Quality Dividend Peers in Biotechnology

AMGN
Amgen
3.21% Yield
GILD
Gilead Sciences
2.79% Yield

MYGN Dividend History: Last 2 Payments (USD) as of February 2026

Ex-Dividend Date Record Date Payment Date Period Dividend per Share Dividend Growth Rate QoQ Payout Yield
2009-07-01 1.75 0% N/A
2009-06-15 1.75 0% N/A

MYGN Dividend FAQ

Myriad Genetics (NASDAQ:MYGN) is a U.S. molecular diagnostics firm that commercializes DNA- and RNA-based tests across oncology, women’s health, pharmacogenomics, and mental-health domains. Its flagship offerings include MyRisk (hereditary cancer risk), BRACAnalysis CDx (germline BRCA companion diagnostic), MyChoice CDx (homologous recombination deficiency in ovarian cancer), Prolaris (prostate cancer aggressiveness), EndoPredict (breast cancer aggressiveness), Precise Tumor Molecular Profile (comprehensive genomic profiling), and a suite of prenatal screens (Prequel, Foresight, SneakPeek). The company partners with Illumina, major cancer centers (MSKCC, MD Anderson, Rochester), Flatiron Health, and SOPHiA GENETICS for liquid-biopsy development.

What is the Dividend Yield of MYGN?

As of February 2026, MYGN`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - USD by the current share price of 5.12.

Does MYGN pay a dividend?

As of February 2026 MYGN does not pay a dividend.

How often does MYGN pay dividends?

Over the last 12 months, MYGN has issued 0 dividend payments. The last dividend payment was made on 2009-07-01.

MYGN dividend forecast

Based on historical data, the forecasted dividends per share for MYGN for the next 4 payments are between 0 (-100.0%) and 0 (-100.0%).
This represents a significant dividend cut compared to the last payment.

Will MYGN pay dividends in 2026?

The latest dividend paid per share was 1.75 USD with an Ex-Dividend Date of 2009-07-01. The next Ex-Dividend date for Myriad Genetics (MYGN) is currently unknown.

What is the next Ex-Dividend Date for MYGN?

The next Ex-Dividend date for Myriad Genetics (MYGN) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of MYGN?

MYGN's average dividend growth rate over the past 5 years is 0.00% per year.

What is the Yield on Cost of MYGN?

MYGN's 5-Year Yield on Cost is -%. If you bought MYGN's shares at 30.35 USD five years ago, your current annual dividend income (- USD per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of MYGN?

MYGN Payout Consistency is 1.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Very unstable: Myriad Genetics has a poor track record of dividend payments over its lifetime.

Does MYGN have a good Dividend Yield?

MYGN`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of MYGN?

The Dividend Payout Ratio of MYGN is unknown.

What is the Dividend Rating of MYGN?

MYGN`s Overall Dividend Rating is 1.00%. Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

MYGN Outstanding Shares Analysis

What is the Trend in MYGN's Outstanding Shares?

Myriad Genetics's outstanding shares have increased by approximately 3.99% annually over the past 3 years (Trend Reliability: 100.0%).

Watch carefully: The company is issuing new shares, diluting existing shareholders. Dividend growth may lag earnings growth as payouts are spread across more shares.

Has MYGN ever had a Stock Split?

Yes, the last stock split was on Mar 26, 2009 with a ratio of 2:1.

This was a forward split: Each share became 2 shares, lowering the price proportionally. The dividend per share was also adjusted downward by the same ratio, so total dividend income remained unchanged.

Year Number of Shares Annual Growth Rate
1995 35,000,000
1996 35,000,000
1997 38,333,300 +9.52%
1998 38,666,700 +0.87%
1999 40,495,600 +4.73%
2000 45,396,200 +12.1%
2001 47,215,400 +4.01%
2002 50,162,000 +6.24%
2003 54,218,000 +8.09%
2004 61,364,000 +13.18%
2005 71,094,000 +15.86%
2006 79,616,000 +11.99%
2007 88,188,000 +10.77%
2008 97,716,000 +10.8%
2009 99,426,000 +1.75%
2010 93,647,000 -5.81%
2011 86,231,000 -7.92%
2012 84,240,000 -2.31%
2013 76,825,000 -8.8%
2014 75,401,000 -1.85%
2015 73,800,000 -2.12%
2016 68,300,000 -7.45%
2017 71,900,000 +5.27%
2018 76,500,000 +6.4%
2019 74,400,000 -2.75%
2020 75,300,000 +1.21%
2021 79,900,000 +6.11%
2022 81,500,000 +2%
2023 86,100,000 +5.64%
2024 91,100,000 +5.81%
2025 93,100,000 +2.2%

Key Metric Definitions

Dividend Yield
Annual dividend per share divided by current share price.
Payout Ratio
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Payout FCF
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Growth Rate (CAGR)
Compound annual growth rate of dividends over the last 5 years.
Consistency
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Yield on Cost
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Streak
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Dividend Rating
Proprietary score (0-100) combining yield, growth, safety and consistency.

Last update: 2026-02-02 02:16